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The canine prostate is peculiarly suitable for studies of the normal function 
of this organ and of its neoplasms as well. This gland in a normal young adult 
dog is of considerable  size and its large host is docile and long lived under 
laboratory conditions,  under which it thrives.  In aging dogs, as in man, the 
prostate commonly becomes enlarged, often greatly so, because of benign and 
malignant neoplastic growths. Actually the dog is unique among the laboratory 
animals in this regard.  Further, the reactions of the dog to the administration 
of physiologically active steroid substances  resemble those of man, in contrast 
to many other species of lower animals. 
In earlier papers in this series (1, 2) methods were described whereby canine 
prostatic neoplasms were induced to enlarge or to dwindle to a striking degree. 
These findings when transferred to patients with widely disseminated prostatic 
cancers  (3)  were  found  also  to  have  validity  in  the  human  being;  the 
growth of these human cancers respectively  could be accelerated  or retarded. 
The retrogression  has proved so common and of such magnitude that anti- 
androgenic  controlling  measures  have been  adopted as standard therapeutic 
measures  both for clinical patients and for dogs with appropriate prostatic 
neoplasms. 
In this paper we again deal with the canine prostate and especially with the 
interaction of physiologically active steroids thereon, and a correlation is made 
with the function of a salivary gland since both the prostatic and submaxillary 
glands are greatly stimulated by the alkaloid, pilocarpine. 
The prostatic  secretion  reflects  chemical  activity of prostatic  epithelium 
which is a  target structure dependent for its activity on steroids  elaborated 
in the testis and other remote tissues,  that in turn, are contingent for their 
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function on proteins formed in the hypophysis; we designate this functional 
ensemble the male genital complex. 
TEXT-I~o. 1. The prostatic isolation operation. The connection of the prostatic urethra 
with the bladder has been severed and the prostatic secretion is collected by way of the 
pen~. 
The only method which has been available hitherto for the measurement with 
precision of the activity of this system in living mammals has been the quanti- 
tative measurement of the  secretion of the prostate  following the prostatic 
isolation operation  (1)  (Text-fig.  1).  The use of this simple device has been 
informative and many efforts have been made by us in the last  13 years to CHARLES  HUGGINS  AND  JOHN  L.  SOMMEP.  665 
improve  the procedure but only 3  modifications have proved  to  be  useful: 
(1)  A light metallic cannula of wide bore is now used to replace the original 
heavy, narrower brass tube, with consequently an important decrease in in- 
fection of the urinary tract, promoting better health of the dogs. (2) The ap- 
paratus for collecting prostatic fluid has been improved (Text-fig. 1). 
TzxT-FIo. 2. The prostatic translocation operation. The glass device used for the quan- 
titative collection  of prostatic fluid is represented at the lower right. 
(3)  The utility of the investigative method has been increased in another way 
by use  of the prostatic  translocation operation  (Text-fig. 2)  here to  be  de- 
scribed. In the dog it is possible to dislocate the prostate from its natural bed 
and to transpose it to the perineum where it survives (Fig. 1). The novel fea- 
tures of the new procedure are not only that it permits the size of the prostate to 
be measured but it provides the prostatic fluid unmixed with other materials. 
After the earlier prostatic isolation operation the secretion of the prostate was 556  PROSTATIC SECRETION.  III 
obtained in a  series of jets, since the fluid accumulated in the prostatic urethra 
until sufficient pressure was built up to open the external sphincter, whereas by 
the new procedure  the prostatic fluid is delivered directly to  the outside and 
continuously during secretion, allowing the secretory curve to be determined. 
Estrogens  and androgens when supplied  together  in appropriate  amounts result 
in a  considerable modification of the characteristic effects of either compound given 
separately. De Jongh  (4)  seems to have been the first to discover the interaction of 
pure androgenic and estrogenic steroids,  a  topic which has been reviewed recently 
(5); aside from previous data on prostatic secretion of the dog (2), which are extended 
in the present paper, the indicators of steroid interaction have been exclusively struc- 
tural characteristics, not measures of function, and the end results could be expressed 
only in semiquantitative terms.  The  following specific effects  induced by estrogen 
are known to be prevented by supplementary androgen: (a) Squamous metaplasia in 
the prostate (4); (b) vaginal comification (6); (c) endosteal proliferation of bone with 
pubic resorption in mice  (7);  (d)  perineal turgescence in apes  (8).  The addition of 
estrogen causes a decrease in height of the comb of capons being injected with andro- 
gen (9).  On a  weight basis estrogens are more effective than androgens in inducing 
steroid interaction in all these indicators except in the comb where very large amounts 
of estrogen do not completely counteract the growth effect of much smaller quantities 
of androgen (9, 10). 
Mettwds 
All the operations were performed with precautions for asepsis on dogs under anesthesia 
induced by the intravenous injection of sodium seconal,  25 rag. per kg. of body weight dis- 
solved in 10 cc.  of water.  Procaine penicillin, 300,000 units, was injected daily for a  few 
days after operation. 
Prostatic Translocation Opctation.--During the period in which the prostate is acquiring 
blood vessels by ingrowth, in its new domicile in the perineum, the gland must survive for 
a  few days on vascularization from the urethra, which is the limiting factor of the proce- 
dure; the smaller the prostate the less of this accessory  blood supply is required. 
Prior to the operation cannulae were machined from a stainless steel rod 3 cm. in diame- 
ter  to  form  a  thin  circular  disc  (3  cm.  in  diameter)  on  one  end  of  a  thin  tube 
1.2 cm. in diameter and 10 cm. long; the weight of the finished  cannula was 25 to 30 gin. 
Dogs with small prostatic glands as determined by rectal palpation were  selected,  the 
most satisfactory being large, partly grown dogs,  3 to 5 months of age,  prepubertai, and 
8 to 15 kg. in weight. In a few cases adult dogs with mature prostatic glands were used suc- 
cessfully. 
The abdomen was opened through an incision in the lower right quadrant. The fat pads 
and peritoneum covering the prostate were dissected  away. The bladder neck was cut across 
and the proximal defect closed with a  catgut suture. The cannula was then placed in the 
dome of the bladder which was closed  snugly around it with catgut sutures; the tube was 
brought to the outside through a "stab" incision in the lower left quadrant. 
The prostate was then moved to its new location (Text-fig.  2). The vasa deferentia and 
all the blood vessels  entering the prostate from its posterior aspect were ligated and sec- 
tioned; the prostate was now freely movable except for its attachment to the urethra below. 
A finger was then inserted between the prostate and rectum as far as the perineal muscles 
to serve as a guide for another incision which was made transversely in the skin of the peri- CHARLES  HUGGINS  AND  JOHN  L. SOM-~ER  667 
neum anterior to the rectum. An opening was made in the levator ani  muscles upon the tip 
of the finger in the abdomen and  the prostate was drawn  through the hole in the muscles 
into the perincum.  A  subcutaneous pocket in the perincum was then formed for the pros- 
tare.  The transected  prostatic portion of the bladder  neck was  then  sutured  to the skin. 
Finally all the incisions were closed in layers. 
Submaxillary Duct Fistula.--To gain comparative data on salivary secretion a  fistula of 
Wharton's duct on the left side was made at the same sitting as follows: The jaws of the 
dog were opened wide and incisions were made in the floor of the mouth on either side of 
the duct,  which is easily visible, the incisions meeting in surrounding  the salivary papilla 
to  form  an  acute  angle.  A  flap  of  buccal  mucosa  containing  the  duct  was  raised  and 
an opening made bluntly in the muscles of the floor of the mouth with an incision directly 
below it in the skin. The mucosa containing Wharton's duct was drawn  through  the inci- 
sion and sutured to the skin with silk, using due care that the mueosal flap was not angu- 
lated or under tension. 
Experimental Techniques.--Observations on  prostatic  and  salivary  secretions  were  not 
begun until all the incisions had healed and the dog was in good health. 
The salivary and prostatic secretions were measured in fractions for 1 hour following the 
injection of pilocarpine hydrochloride, 5 mg. dissolved in 1 cc. of water, into the long saphe- 
nous vein at the ankle. This will be designated the standard pilocarpine stimulus. Saliva was 
collected in a  thistle tube connected to a  calibrated centrifuge tube; a  special glass collect- 
ing device (Text-fig. 2) was used for the prostatic secretion. These assays were made 3 times 
each week. 
In  certain  cases  testosterone  propionate  and  stilbestrol  x dissolved in  sesame  oil were 
injected intramuscularly, always in different areas.  Studies of the interaction of these sub- 
stances on the prostate are based  on observations made on 15 dogs.  During the investiga- 
tion 2 dogs were found with Sertoli cell tumors (11) of the testis with resulting feminization 
and  these prostatic  glands were available for comparison with those of dogs injected with 
estrogen. 
The size of the prostate was estimated by caliper measurements of length and breadth of 
the gland. From these diameters, volume was calculated by the formula ~ ~.,a. These calcu- 
lations assume that the shape of the gland, above the minimum, does not vary with changes 
in size and that the form is spherical. 
The acid phosphatase  content of prostatic fluid was determined by the method of King 
and Armstrong (13). 
Slices  of the prostates  were fixed  in formalin and  stained  with hematoxylin and  eosin 
for microscopic purposes. 
RESULTS 
Characteristics of the Pilocarpine-Induced Secretions.--In the morning before 
feeding, secretion by the left submaxillary gland and the prostate is so sluggish 
as  to  be  barely  perceptible.  After  the  injection  of  pilocarpine  these  glands 
secrete briskly.  Submaxillary  saliva  (Table I)  appears  about  20 seconds after 
the injection of pilocarpine. 
The  volume  of  saliva  secreted  in  1  hour  following a  standard  pilocarpine 
stimulus  fluctuated  over only a  small  range.  There  were differences between 
individual dogs but each animal tended to secrete for many months an amount 
x The  authors  are grateful  for gifts  of  the  steroids  used  to  the  Sehering  Corporation, 
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characteristic of it (Table I). No differences were detected in the appearance 
time or the volume of saliva in dogs of from 10 to 21 kg., whence it would 
appear that body weight was not involved in an important way, No differences 
were  observed in  the  characteristics of submaxillary secretion between  un- 
treated castrate dogs and the same animals injected with androgenic or estro- 
genic steroids or combinations thereof. When pfloearpine was injected intra- 
muscularly the appearance time of the prostatic and salivary secretions was 
prolonged; the route of administration (12) of the alkaloid is critical in obtaining 
standardized values. 
TABLE I 
Effect of Pilocarpine on tle Appearance  Time and  tie Amount  of Secretion  of tie Left Sub- 
maxillary Gland 
Response to an intravenous injection of 5 rag. of piloearpine hydroehlofide: saliva col- 
lected for 1 hour. 
Appearance  Period of  No. of tests  Salivary volume  Dog No.  observation  tlme 
9-29 
1-20 
8-'0 
2-83 
days 
112 
43 
63 
174 
36 
19 
24 
70 
20  -4- 4.0 
20.5 4- 4.1 
20.8  4- 3.1 
22.0  -4- 3.5 
36.6 4- 5.8 
45,1  4- 4.3 
58.8  4- 3.5 
39.7  4-  5.0 
In untreated castrate dogs  pilocarpine evoked no prostatic secretion, but 
after testosterone was given to these animals prostatic secretion occurred, and 
as the first detectable evidence of growth of the gland, prostatic fluid appeared 
4 to I0 minutes after a standard pilocarpine stimulus. At this point in the ex- 
periment saliva was much more prompt in its appearance than prostatic fluid 
but with increasing growth of the prostate, the appearance time became shorter 
(Text-fig. 3) until a minimum time of 12 to 15 seconds was reached; now the 
prostatic fluid appeared earlier than the saliva. 
The volume of prostatic secretion was commonly less than that of the single 
submaxillary gland, but after prolonged treatment with large doses of testos- 
terone propionate (20 rag. daily) the amount of prostatic secretion sometimes 
exceeded that of the submaxillary gland, reaching more than 60 cc. in I  hour. 
A  comparison of  the  measurements of appearance  time with the volume of 
prostatic fluid reveals that the former supplements but cannot substitute for the 
latter as  an assay method for estimation  of prostatic growth and  secretory 
activity; after the  minimum  appearance time of secretion has been reached 
the prostate is still  capable of secreting  increasing  amounts  of fluid  in  any 
given period of time, I hour for example. 
The secretory curves of the prostate and the submaxillary gland were similar 
(Text-fig. 4). When the logarithms of time and of volume of the secretions were CHARLES  HUGGINS  AND  JOHN  L.  SOMMER  669 
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Tgxz-Fzo. 3. The time of appearance of submaxillary saliva and prostatic fluid, and the 
volume of prostatic secretion after a  standard pilocarpine stimulus in a  castrate dog (9-29) 
injected with testosterone propionate. 
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TExT-FIo.  4.  Curves of volume of  secretion of  prostatic fluid  and  submaxillary saliva 
respectively after a  standard pilocarpine stimulus in their relation to time. 670  PROSTATIC  SECRETION.  III 
plotted as abscissae and ordinates respectively a  straight line was obtained. 
An  equation which expressed  the  relationship  between time (t),  volume (v) 
per unit of time, and slope of the line (m) is 
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"I~xT-F~G. S.  Decrease of  volume  of prostatic  secretion of a  castrate  dog,  previously 
maintained  on injections of testosterone propionate,  during 2 periods of its withdrawal, of 
7 and 14 days respectively.  No changes took place in the salivary volume.  Secretions col- 
lected for 1 hour, following the standard pilocarpine stimElus. 
in which c is a  constant for any particular fluid collection, being  the point 
of intersection of the straight line with the y axis of the logarithmic scale. 
When  testosterone  propionate  in  a  castrate  dog  was  suddenly  discon- 
tinued,  the  prostatic  secretion  diminished rapidly  in  volume but  this  was 
restored  when  the  androgen  injections  were  resumed  (Text-fig.  5).  These 
procedures have no effect on salivary volume. The volume of saliva was like- 
wise unaffected by the administration of large amounts of testosterone and 
stilbestrol (Text-fig. 7). 
The prostatic fluid from the fistula after the translocation  operation was 
water-clear  and  in  our  experience  never became  infected. Rarely an  occa- 
sional leucocyte was observed in the fluid. When estrogen was injected into CHARLES  HUGGINS  AND  ~'OHN  L.  SOMMER  67l 
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a  dog with translocation of the prostate only a  few squamous cells and mac- 
rophages appeared  in  the  fluid from the fistula,  whereas  in  dogs which  had 
been subjected  to  the prostatic  isolation  operation  as a  result  of which  the 
prostatic fluid by necessity had  to  traverse the urethra  very large numbers 
of  these  cells,  obviously derived  from  the  urethral  mucosa,  appeared  after 
the estrogenic treatment. 
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T]~xT-Fm. 6.  Volume of the prostate of a castrate dog maintained on testosterone pro- 
pionate  10  nag.  daily.  Discontinuing the androgen injections caused a  prompt decrease of 
size which was restored when androgen was resumed. The addition of stilbestrol, 0.5 nag. 
daily, caused a slight decrease in volume of the gland, and now increasing the amount of 
testosterone propionate did not result in an expected increment of gland size. 
Size of the Prostate  as Affected  by the Steroids  Administered.--It  has  long 
been known  that  testosterone  increases  the  size  of  the  prostate  of castrate 
animals  and  that  its  withdrawal  effects a  decrease,  but  these  relationships 
have not been placed on a  quantitative basis.  The effect on the  size of the 
prostate of a  castrate dog  induced by administering,  and  later withdrawing 
testosterone is shown in Text-fig. 6. 
Prostatic  growth  and  secretion  in  the  dog  occurred  at  a  low  rate  when 
testosterone propionate,  2  rag.  daily,  was  injected  and  the  effects of 5  rag. 
dosage  were  moderate;  daily  injections  of  testosterone  propionate,  10  rag., 
induced  rapid growth and secretion  (Text-fig. 3). When testosterone was ad- 672  PROSTATIC  SECRETION.  III 
ministered to a  castrate dog for periods varying from 18 to 50 days at each 
of four increasing  dose levels,  the volume of the  prostate  increased  (Table 
II)  with  each  androgenic  increment,  forming a  series  of  flattened  curves. 
The height of the growth level reached varied from dog to dog, presumably 
owing  to heterogeneous biological characteristics of members of this  series. 
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~x~-FIO.  7. Secretion of prostatic  fired  and submaxillary saliva  in a c~strate dog treated 
with testosterone propionate and stilbestrol. Neither compound had a significant effect on 
the volume of saliva. Stilbestrol, 0.5 rag., reduced significantly the volume of prostatic se- 
cretion, while testosterone propionate, 10 rag., was injected, resulting in a secretory plateau. 
Increasing the testosterone propionate to 20 rag. and later to 40 rag. daily did not raise the 
plateau whereas increasing stilbestrol to 5 mg. lowered  it greatly. 
In  any given individual  dog,  the volume of the  gland bore a  simple arith- 
metic relationship to the amount of testosterone administered. 
When the estrogen, stilbestrol 0.5 rag. daily, was administered in addition 
to androgen (testosterone propionate,  10 rag.)  a  significant decrease in pros- 
tatic volume occurred, of the order of about one-third  (Text-fig. 6).  More- 
over when this estrogen ievel was kept constant and the amount of androgen 
was  doubled  the  expected doubling of volume of the  gland did  not  occur; 
the anticipated growth of the gland was blocked by the estrogen. 
Interaction  of Androgenic  and  Estrogenic Compounds  on  the  Prostate.--It 
has been established  (2)  that stilbestrol, 0.5  rag.  daily, will completely sup- 
press  prostatic  secretion in  normal  adult  dogs.  The following concerns cas- CHARLES  HUGGINS  AND  ~OHN  L.  SOMMER  673 
trate dogs treated for periods of weeks or months at each level with combina- 
tions  of steroids.  The dosage of the  compounds  is  given in milligrams per 
diem.  It was  found that  in  the dog these  steroids in  the amounts adminis- 
tered did not depress the appetite or cause a  loss of weight, and all the ani- 
mals seemed to be healthy throughout the observational periods. 
When  testosterone propionate was  injected in moderate quantity  (10 rag. 
daily)  without  accompanying  estrogen,  prolonged  and  steadily  increasing 
secretion of prostatic fluid occurred (Text-fig. 3)  for about  3  to 5  months, 
when the volume reached a level. When stilbestrol, 0.1 to 0.3 rag., was added 
no effects of the estrogen on this curve were detected. Further, no cytologic 
changes characteristic of the estrogenic compound were observed in the pros- 
TABLE II 
E~ect of Testosterone on the Volume of the Prostate of Castrate Dogs* 
The volume of the gland in cubic centimeters is the average of many measurements of 
the height of growth plateau developing with each level of androgen. 
9-29 
7-52 
8-45 
1-12 
2-83 
Daily amounts of testosterone proplonate, the number of days injectedm 
and prostatic volume 
2.5 rag.  5 rag.  10 rag.  20 rag. 
days  ¢¢. 
25  1.4 
25  1.6 
days 
30 
41 
34 
G$° 
3.0 
4.8 
2.1 
days  ¢£. 
25  5.6 
27  5.2 
50  10.5 
18  4.1 
170  ~  17.0 
days 
21 
13 
CC. 
12.8 
10.3 
* The subjects were immature dogs. 
tate.  Conversely,  supplementing  small  amounts  of  testosterone  propionate 
(5  rag.)  with  relatively large amounts  of stilbestrol,  1 to 5  mg.  daily,  sup- 
pressed the prostatic secretion and the epithelium of the prostate ceased to 
be cylindrical, becoming atrophic'--a matter taken up further on. 
When dogs were injected daily with testosterone propionate, 5  to 20 mg., 
a  dosage of stilbestrol could be found which caused the rising curve of pros- 
tatic secretion to break sharply in a  downward direction. The deflection was 
usually observed within  2  days after estrogen injections were begun, but in 
2 dogs it was delayed for 9 and 12 days respectively. In 10 dogs (Table III) 
receiving testosterone propionate, 10 mg., this critical value of stilbestrol was 
0.4 to 0.6 mg. In a single exception (dog 9-07) as much as 1 mg. did not cause 
a  decrease of secretion but 5  rag.  amounts were effective; this dog weighed 
28 kg.  and was  the heaviest in the series.  The critical amount of stilbestrol 
(0.5 rag.) was equally efficacious in dogs receiving 10 or 20 mg. of testosterone 
propionate. 
In  those dogs receiving testosterone propionate,  10 rag.,  in which stilbes- 674  PROSTATIC  SECRETION.  ILl 
trol,  0.5  rag.,  was capable  of reducing the  prostatic  secretion,  the  curve be- 
came  nearly  flat  at  a  low  level  after  10  to  21  days  (Text-fig.  7).  Although 
the amount of secretion was greatly reduced, its volume was still considerable; 
TABLE III 
Effects  of Interaction  of Testoaerom  Propionate  and  Stilbestrol on  the  Volume  of Prostatic 
Secretion of Castrate Dogs 
Dog No.  Stilbestrol 
reg.~day 
Period of 
treatment 
days 
Volume of prostatic  secretion 
Original  i  Plateau 
sG.  I  cG. 
Change 
(a)  Testosterone propionate, 5 mg. daily 
9-82  i  1.0  [  29  ]  12.2  I  0.2 
(b)  Testosterone propionate,  10 rag. daily 
5-10 
5-10 
5-10 
9--O7 
2-83 
1-40 
8-24 
8-88 
2-89 
5-10 
1-64 
9-4O 
O-57 
9-O7 
9-O5 
9-O7 
7-20 
8-45 
9--29 
2-89 
9--07 
0.1 
0.2 
0.4 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.6 
0.6 
0.6 
0.8 
1.0 
1.0 
5.0 
5.0 
24 
21 
20 
28 
21 
27 
20 
35 
33 
17 
15 
21 
21 
25 
30 
14 
38 
19.4 
29.2 
19.6 
7.0 
24.8 
3.5 
2.3 
10.0 
4.8 
4.8 
1.8 
1.0 
4.0 
6.3 
3.0 
0.2 
0.1 
15.4 
19.4 
30.1 
7.0 
36.0 
7.4 
7.2 
31.4 
23.4 
16.2 
6.2 
6.6 
9.0 
5.0 
18.4 
6.3 
10.2 
20 rag. daily 
29.5 
54.0 
(~  Testosterone propionate, 
0.5  11  20.3 
0.5  11  39.3 
(d)  Testosterone propionate, 40 mg. daily 
5.0  I  13  7.0  I  0.6 
5.0  I  20  10.0  I  0.5 
--98.4 
+26.0 
+50.5 
--34.9 
0 
--31.1 
--52.7 
--68.0 
--68,2 
--79,5 
-70.4 
-71.0 
--84.8 
-55.6 
+26.0 
-83.7 
-96.8 
-99 
--31.2 
--27.8 
--91.4 
--95.0 
the level of the plateau  indicated a  reduction of 31  to 79 per cent of the ini- 
tial  secretion.  The  acid phosphatase  levels  were  in  the  range  of  146  to  378 
King-Armstrong units  (13)  per  100 cc.,  which  is of the  order  found for this 
enzyme in the prostatic fluid of dogs injected with androgen alone  (12).  The 
low  plateau  persisted  for  many  weeks  while  androgen  and  estrogen  were 
given  in  the  stated  amounts,  and  wheu  testosterone  propionate  was  raised CHARLES HUGGINS AND JOHN L.  SOMMER  675 
to  20 or 40 rag.  daily the prostatic secretion did not increase  (Text-fig. 8). 
Moreover,  a  new  and  still  lower plateau  was  reached when stilbestrol  was 
increased to 0.75  to  1.0 mg.  quantities,  maintaining  testosterone propionate 
at  10  rag.  Stilbestrol  in  5  mg.  amounts  greatly reduced but  did  not  com- 
pletely suppress prostatic secretion in dogs receiving 10 to 40 mg. of testos- 
terone  propionate  (Text-fig.  7);  the  secretion per  hour  after  the  standard 
pilocarpine stimulus ranged from 0.2 to 0.5 cc. (Table III) and the acid phos- 
phatase content was high. 
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T~xT-Fm. 8. The prostatic secretion decreased considerably in a castrate dog when stil- 
bestrol, 0.5 rag., supplemented injections of testosterone propionate; increasing the amount 
of androgen did not augment the secretion. 
Microscopic examination of sections of the prostate of dogs  treated with 
testosterone  propionate,  10  rag.,  and  stilbestrol,  0.5  to  1.0  rag.,  disclosed 
large  areas  of atrophic  (Fig.  2)  or  squamous  epithelium but  columnar epi- 
thelium was present as well (Figs. 3 and 4). These mixed findings resembled 
those which we observed in the prostatic glands of 2 dogs with spontaneous 
testicular tumors derived from Sertoli cells.  Their prostates were large,  23.8 
and 27.6 gin. respectively, and squamous metaplasia was present throughout 
the entire glandular epithelium  (Fig.  5)  except in a  rim of tissue in the an- 
terior region of the gland where there was columnar epithelium (Fig. 6). 
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of  testosterone  propionate  (40  rag.)  and  stilbestrol  (5  mg.)  for 30  and  49 
days respectively became large, weighing 25.6  and 30.5  gin.  Sections of the 
prostate  revealed  atrophic  and  squamous  epithelium  and  also  great  num- 
bers of cylindrical epithelial cells of normal appearance (Fig. 4). It was clear, 
however, that the functional activity of these cylindrical cells  had been de- 
pressed by the estrogenic compound. 
There were differences in the response of prostatic epithelium to estrogen, 
which were topographic. In order of decreasing sensitivity these were: veru- 
montanum and  the  overlying urethral  epithelium; prostatic  ducts;  acini in 
the posterior region of the prostate; a  rim of anterior acini. All the epithelial 
cells of the prostate have been observed to become involved in the estrogenic 
change after prolonged  treatment with large amounts of estrogen combined 
with  small  amounts of androgen.  The  changes induced in  the  prostate  by 
estrogen  were  completely  reversed  when  estrogen  was  stopped  and  testos- 
terone was administered. 
DISCUSSION 
In this research each subject served as its own control. The prostatic secre- 
tion was standardized under a  a  rather rigid set of experimental conditions 
prior  to  further  experimentation,  and  only  a  single  modifying factor  was 
introduced at one time. While most of the dogs reacted similarly to the in- 
fluences described,  there  were  occasional quantitative  differences in  the  re- 
sponse to steroids, no doubt related to the heterogeneous nature of the bio- 
logical material. 
The dosage and route of administration of pilocarpine are critical factors in 
quantitative  studies  of prostatic  secretion  and hence  the  rate  of  secretion 
from a  salivary fistula was utilized to serve as an indicator of the strength of 
the alkaloid stimulus. The prostatic secretion is profoundly affected by andro- 
genic and estrogenic compounds whereas the salivary secretion proved to be 
uninfluenced. Variations in salivary secretion in response to pilocarpine were 
unusual  and  small  in  any  individual  dog,  indicating  that  such  important 
links  in  secretion  as  the  neuromuscular  apparatus  and  epithelium  of  the 
salivary gland remained in a  steady state under the experimental conditions 
employed. 
When supplied separately in effective amounts androgen is known to in- 
duce prostatic secretion in immature or castrate dogs, whereas estrogen sup- 
presses  it  in  the  intact  adult  male.  Each  produces  characteristic  cellular 
changes in  the prostate;  androgen is  responsible for  tall  cylindrical epithe- 
lium; estrogen causes flattening and layering of the cells  to form squamous 
non-secretory elements.  Both  types of  cells  are  present  in  the  dog  treated 
with  relatively large  quantities  of  estrogen  and  androgen,  duplicating  the 
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occurring testicular neoplasms. These structural changes must be considered 
as factors in the interpretation of the interaction of steroids on the prostatic 
cells. We observed a  decreased secretory response to pilocarpine before cyto- 
logic changes characteristic of estrogen were evident. While cylindrical epi- 
thelium is necessary for secretion by the prostate, we observed that it may 
be present in a  state wherein the secretion is greatly depressed (Fig. 4). This 
phenomenon  has  been  observed  previously  in  the  hypertrophied  prostatic 
glands of senile dogs (2),  these very large glands with much columnar epi- 
thelium secreting only small quantities of fluid. 
The estrogenic changes occur in a sequence which is correlated with topog- 
raphy, the epithelium of the anterior region of the prostate being less respon- 
sive to estrogen than that in the acini of the posterior portion or in the ducts. 
This variance  of  response  in  the prostate  is  best explained on the basis of 
differences in threshold response to estrogen within the structural unit. Moore 
and Gallagher (14)  demonstrated such a  threshold with respect to different 
organs;  the prostate  of the  rat  responds  to  approximately one-third of the 
amount of androgen required by the  seminal vesicle indicating a  threshold 
difference between these organs of the male genital complex. 
We observed that the effect of physiologically small amounts of estrogen 
when supplemented with large amounts of testosterone propionate,  10 to 40 
rag., was completely nullified by the activity of the androgen; the secretory 
curve continued to rise in the customary manner and there were no "estro- 
genic" changes in the gland. The maximum amount of stilbestrol, the effect 
of which could be concealed in this physiologic way, was in the neighborhood 
of 0.3 rag. daily. The action of functionally small amounts of androgen when 
supplemented with large amounts of stilbestrol,  1 to 5 mg. daily, was com- 
pletely averted by estrogenic activity; prostatic secretion was suppressed and 
all  the  epithelium  of  the  prostate  showed  squamous  or  atrophic  changes. 
The upper limit of testosterone propionate which could be masked in this way 
was in the neighborhood of 5 mg. 
In our dogs treated with testosterone propionate at  10  to  20 mg.  levels, 
moderate amounts of stilbestrol  (usually 0.5  mg. daily) caused a  sharp de- 
flection of  the  rising  secretory  curve  which  steadily  decreased  to  reach  a 
lower level after a  time, that was steadily maintained for many weeks. The 
content of acid phosphatase in the fluid indicated that it was of the order of 
that of the normal prostatic secretion. The new plateau was not raised by 
increasing testosterone propionate  to as much as 40 mg.  daily. A  new and 
still lower level was reached when the estrogen was increased slightly (stil- 
bestrol 0.75 to 1 mg. daily). We designate this effect the plateau phenomenon 
and it can be explained most reasonably in the following terms: on a  weight 
basis stilbestrol is more efficient than testosterone propionate; due to a differ- 
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stimulus while other cells are unaffected and continue to secrete, being domi- 
nated by the androgen; while certain estrogenic effects are structural, others 
are  functional not causing detectable anatomic change in the prostatic epi- 
thelium.  Of  testosterone and  stilbestrol,  the  latter  is  the  more  dominating 
compound on prostatic epithelium and its effects are not displaced by quad- 
rupling the amount of testosterone propionate.  The plateau phenomenon is 
remarkable,  indicating that the manifold and complex effects of androgenic 
and estrogenic compounds can remain in close  balance for a  long while.  It 
was  of considerable  interest that  the balance  could be  disturbed easily by 
small  increments  of  estrogen,  which  caused  a  depression  of  the  secretory 
curve to form a  new and lower plateau, whereas very large increases of tes- 
tosterone failed to elevate this secretory level. 
When functionally large quantities of stitbestrol (5 mg.) were injected with 
large amounts of testosterone propionate (40 mg.), again there was evidence 
of the presence of both compounds. The prostates were large; the prostatic 
secretion while greatly decreased in amount was not completely suppressed; 
and the content of acid phosphatase was similar to that of the prostatic fluid 
of normal adult dogs. Areas of atrophic and squamous epithelium were promi- 
nent in sections of the prostate, but also there were great numbers of cylin- 
drical  epithelial  cells,  obviously with  function  depressed,  especially in  the 
anterior rim of the prostate. In sum, the activity of both estrogenic and an- 
drogenic compounds was manifest when the  steroids were  injected in large 
amounts. 
SUMMARY 
The prostate of the dog was relocated permanently in the perineum where 
its size could be measured and correlated with the output of prostatic secre- 
tion during many months.  The  secretion of a  submaxillary gland obtained 
through a fistula was utilized as an internal biologic standard of the effects of 
pilocarpine, the secretory stimulus employed, because the amount and route 
of administration of the alkaloid are critical factors in inducing secretion. 
Prostatic secretion was found to be profoundly affected by androgenic and 
estrogenic compounds, in contrast to salivation. The curves of the secretory 
response of the prostate and submaxillary glands to pilocarpine proved to be 
similar and a  mathematical formula has been constructed to  represent them. 
When  testosterone  propionate  was  administered  in  increasing  quantities 
for periods of weeks at each level, the volume of the prostate increased in a 
series of flattened curves. This volume, under the conditions mentioned, was 
found to stand in a  simple arithmetic relationship to the amount of testos- 
terone propionate administered. 
Moderate quantities of testosterone propionate masked the effects of small 
amounts of  stilbestrol  on  the  prostate.  The  reverse  was  also  true and  the 
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The  amounts of  stilbestrol  were  determined which  lowered  the  quantity 
of prostatic secretion resulting from the simultaneous administration of mod- 
erate  amounts of testosterone propionate  in castrate  dogs,  the result being 
a  level and flat secretory curve which was maintained for many weeks. We 
designate this effect the plateau phenomenon. When this amount of estrogen 
was continued, and the dosage of testosterone propionate greatly augmented, 
the prostatic secretion did not increase in volume. Very slight increases above 
the  critical  amount  of  stilbestrol,  however,  caused  the  secretory  curve  to 
fall to new and still lower levels though the secretion was never completely 
suppressed.  The acid phosphatase  content of the prostatic  secretion in  the 
regions  of  secretory plateaus  was  similar  to  that  of  castrate  dogs injected 
with androgen alone. The plateau phenomenon is due to simultaneous phys- 
iologic action of androgenic and estrogenic compounds on the prostatic cells. 
The depression of prostatic secretion resulting in the plateau phenomenon 
is due to both functional and structural changes in the prostatic epithelium. 
They are best explained on the assumption that differences in steroid thresh- 
old exist in groups of cells  within the prostate,  those of the anterior rim of 
the gland being least susceptible to estrogenic activity. 
Without the technical assistance of Eustus Lauagan this work would have been impos- 
sible; his devotion contributed much to maintaining the dogs in good health. 
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EXPLANATION  OF PLATES 
PLATE 34 
FIG. 1.  Situation of the gland after the prostatic translocation operation. A drop of 
secretion  shows the situation of the outlet. 
FIG. 2.  Atrophic prostatic epithelium found 40 days after supplementing testo- 
sterone propionate, 10 rag., with stilbestrol,  1 rag. This and the succeeding sections of 
Figs.  3-6 were taken at a magnification of 400. All were stained with hematoxylin 
and eosin. 
FIG. 3.  Cylindrical epithelium in the prostate of dog 9-07 treated with stilbestrol, 
5 rag. daily for 49 days; during this period 1400 rag. of testosterone propionate was 
injected. The prostatic secretion was greatly depressed  in volume. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL.  97  PI~TE  34 
(Huggins and Sommer: Prostatic secretion. III) PLATE 35 
FIG. 4.  Cylindrical and squamous epithelium existing together in the prostate of a 
castrate dog injected with testosterone propionate, 10 mg., and stilbestrol, 0.5 rag. for 
49 days. 
FIG. 5.  Squamous metaplasia in the posterior region of the prostate of a dog, which 
had a feminizing tumor of the Serto]i cells of the testis; dog 3-57. 
FIG. 6.  Tall epithelium in the anterior region of the prostate of dog 3-57; compare 
Fig. 5. THE  JOURNAL  OF  EXPERIMENTAL  MEDICINE  VOL. 97  PLATE  35 
(Huggins and Sommer: Prostatic secretion. III) 